Technology & Science
Apr. 6, 2011
Approval Process Gets Tougher for Biotechs
The odds of a new drug or medical device winning U.S. Food and Drug Administration approval are not good and, some say, are getting worse.
Daily Journal Staff Writer
The odds of a new drug or medical device winning U.S. Food and Drug Administration approval are not good and, some say, are getting worse.
As a result, lawyers say the legal and financial stakes are high and rising for companies whose wagers on FDA approval don't pay off. The agency's unpredictability is causing investors to place fewer bets on biotechnology companies and shareholder lawsuits...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In